Roll Over StudY
Showing 1 - 25 of >10,000
Ascites, Peritoneal Carcinomatosis, Peritoneum Tumor Trial in Chandigarh (Standard Paracentesis, Roll Over Paracentesis)
Terminated
- Ascites
- +3 more
- Standard Paracentesis
- Roll Over Paracentesis
-
Chandigarh, IndiaPostgraduate Institute of Medical Education and Research
Mar 2, 2022
Polycystic Kidney Disease, Adult Trial in Bethlehem (Lixivaptan)
Active, not recruiting
- Polycystic Kidney Disease, Adult
-
Bethlehem, PennsylvaniaNortheast Clinical Research Center, LLC
Jun 7, 2022
Cancer Trial in St. Gallen (Rogaratinib (BAY1163877), Combination drug)
Completed
- Cancer
- Rogaratinib (BAY1163877)
- Combination drug
-
St. Gallen, Sankt Gallen, SwitzerlandKantonsspital St. Gallen
Mar 20, 2022
MDS, Leukemia, Myelomonocytic, Chronic Trial (decitabine, Spartalizumab, Sabatolimab)
Not yet recruiting
- Myelodysplastic Syndromes
- Leukemia, Myelomonocytic, Chronic
- decitabine
- +5 more
- (no location specified)
Aug 5, 2022
Endogenous Cushing Syndrome Trial in Edmonton, Halifax, Sherbrooke (Intervention/Treatment)
Active, not recruiting
- Endogenous Cushing Syndrome
-
Edmonton, Alberta, Canada
- +2 more
Nov 9, 2023
Bronchiectasis Trial (BI 1291583, Placebo matching BI 1291583)
Not yet recruiting
- Bronchiectasis
- BI 1291583
- Placebo matching BI 1291583
- (no location specified)
Apr 26, 2023
ISS T-003 Trial Volunteers (ISS T-003 EF-UP2020)
Not yet recruiting
- HIV Infections
- (no location specified)
Jan 9, 2023
Acute Lymphoblastic Leukemia Trial in Russian Federation (Lyophilized S95014)
Recruiting
- Acute Lymphoblastic Leukemia
- Lyophilized S95014
-
Chelyabinsk, Russian Federation
- +5 more
Apr 25, 2022
Myelofibrosis Trial in Houston (Long-term Follow-up, Quality-of-Life Assessment, Ruxolitinib)
Active, not recruiting
- Myelofibrosis
- Long-term Follow-up
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 7, 2022
NSCLC, Urothelial Carcinoma Trial in Worldwide (Durvalumab)
Enrolling by invitation
- Non-Small Cell Lung Cancer
- Urothelial Carcinoma
-
Newmarket, Ontario, Canada
- +26 more
Aug 2, 2022
HER2-positive Metastatic Breast Cancer Trial in Aurora, Madison (Alpelisib, Tucatinib, Fulvestrant)
Recruiting
- HER2-positive Metastatic Breast Cancer
- Alpelisib
- +2 more
-
Aurora, Colorado
- +2 more
Dec 29, 2022
Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)
Recruiting
- Chronic Myelogenous Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Asciminib single agent
- +5 more
-
Ann Arbor, Michigan
- +49 more
Jan 26, 2023
Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)
Recruiting
- Diffuse Astrocytoma
- +22 more
-
Phoenix, Arizona
- +26 more
Jan 27, 2023
Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (Iptacopan)
Recruiting
- Paroxysmal Nocturnal Hemoglobinuria
-
Brno - Bohunice, Czechia
- +30 more
Jul 29, 2022
Parkinson Disease, Constipation Trial in United States (Active Investigational Treatment ENT-01)
Completed
- Parkinson Disease
- Constipation
- Active Investigational Treatment ENT-01
-
Fountain Valley, California
- +17 more
Mar 21, 2022
Knee Osteoarthritis Trial in United States (Home-based Neuromuscular Electrical Stimulation (NMES) therapy)
Completed
- Knee Osteoarthritis
- Home-based Neuromuscular Electrical Stimulation (NMES) therapy
-
Tucson, Arizona
- +4 more
Mar 16, 2021
Tumors Trial in Worldwide (Everolimus, Sandostatin LAR Depot)
Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Kidney Diseases Trial in Worldwide (DCR-PHXC)
Enrolling by invitation
- Primary Hyperoxaluria Type 1 (PH1)
- +5 more
-
San Francisco, California
- +19 more
Jun 22, 2022
Ovarian Cancer, Breast Cancer Trial in Worldwide (Olaparib)
Enrolling by invitation
- Ovarian Cancer
- Breast Cancer
-
Boca Raton, Florida
- +98 more
Aug 22, 2022
Lymphoid Malignancies Trial in Amsterdam (Idelalisib)
Terminated
- Lymphoid Malignancies
-
Amsterdam, Netherlands(unnamed)
Feb 18, 2020